Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas

被引：0
|
作者：
Jonathan J. Lee
Lynette M. Sholl
Neal I. Lindeman
Scott R. Granter
Alvaro C. Laga
Priyanka Shivdasani
Gary Chin
Jason J. Luke
Patrick A. Ott
F. Stephen Hodi
Martin C. Mihm
Jennifer Y. Lin
Andrew E. Werchniak
Harley A. Haynes
Nancy Bailey
Robert Liu
George F. Murphy
Christine G. Lian
机构：
[1] Brigham and Women’s Hospital,Department of Pathology
[2] Harvard Medical School,undefined
[3] Melanoma Center,undefined
[4] Dana–Farber Cancer Institute,undefined
[5] Harvard Medical School,undefined
来源：
Clinical Epigenetics | 2015年 / 7卷
关键词：
Melanoma; Next-generation sequencing (NGS); Epigenetics; (MDS1 and EV1 complex locus); Ten-eleven translocation (TET); Isocitrate dehydrogenase 2 (IDH2); 5-hydroxymethylcytosine; DNA demethylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Screening of an Indian cohort with breast and/or ovarian cancer by a next-generation sequencing-based panel to detect a high frequency of mutations
    Mannan, Ashraf U.
    Singh, Jaya
    Gadkari, Rupali
    Lakshmikeshava, Ravikiran
    Manek, Payal
    Ramalingam, Ravi
    Manasa, B. P.
    Kapoor, Suman
    Yadhav, Jamuna
    Sankaran, Satish
    Katragadda, Shanmukh
    Veeramachaneni, Vamsi
    Ramamoorthy, Preveen
    Hariharan, Ramesh
    Subramanian, Kalyanasundaram
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] MEK inhibitor treatment is effective in a patient with metastatic carcinoma of the ampulla of Vater with BRAF and NRAS mutations shown by next-generation sequencing
    Tahover, Esther
    Bar Shalom, Rachel
    Bogot, Naama
    Kelsen, David
    Gabizon, Alberto
    ANTI-CANCER DRUGS, 2016, 27 (06) : 569 - 572
  • [43] Targeted Next-Generation Sequencing of a 12.5 Mb Homozygous Region Reveals ANO10 Mutations in Patients with Autosomal-Recessive Cerebellar Ataxia
    Vermeer, Sascha
    Hoischen, Alexander
    Meijer, Rowdy P. P.
    Gilissen, Christian
    Neveling, Kornelia
    Wieskamp, Nienke
    de Brouwer, Arjan
    Koenig, Michel
    Anheim, Mathieu
    Assoum, Mirna
    Drouot, Nathalie
    Todorovic, Slobodanka
    Milic-Rasic, Vedrana
    Lochmueller, Hanns
    Stevanin, Giovanni
    Goizet, Cyril
    David, Albert
    Durr, Alexandra
    Brice, Alexis
    Kremer, Berry
    van de Warrenburg, Bart P. C.
    Schijvenaars, Mascha M. V. A. P.
    Heister, Angelien
    Kwint, Michael
    Arts, Peer
    van der Wijst, Jenny
    Veltman, Joris
    Kamsteeg, Erik-Jan
    Scheffer, Hans
    Knoers, Nine
    AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 87 (06) : 813 - 819
  • [44] Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters
    Dongre, Harsh N.
    Haave, Hilde
    Fromreide, Siren
    Erland, Fredrik A.
    Moe, Svein Erik Emblem
    Dhayalan, Sophia Manueldas
    Riis, Rasmus Kopperud
    Sapkota, Dipak
    Costea, Daniela Elena
    Aarstad, Hans Jorgen
    Vintermyr, Olav K.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Targeted next generation sequencing reveals novel splice site mutations in COL6A3 gene in a patient with congenital muscular dystrophy
    Das Bhowmik, Aneek
    Tallapaka, Karthik
    Uppin, Megha
    Sundaram, Challa
    Dalal, Ashwin
    NEUROLOGY INDIA, 2018, 66 (06) : 1812 - 1814
  • [46] Routine molecular testing of resected early-stage lung adenocarcinoma with targeted next-generation sequencing demonstrates a high rate of actionable mutations
    Stiles, Brendon M.
    Nasar, Abu
    Hussein, Mohamed Kamel
    Ghaly, Galal Rafik
    Ahmed, Mohamed Rahouma
    Port, Jeffrey L.
    Lee, Paul C.
    Nguyen, Andrew B.
    Shostak, Eugene
    Borczuk, Alain C.
    Kluk, Michael J.
    Altorki, Nasser K.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S44 - S45
  • [47] Targeted next-generation sequencing of dedifferentiated chondrosarcoma in the skull base reveals combined TP53 and PTEN mutations with increased proliferation index, an implication for pathogenesis
    Gao, Lu
    Hong, Xiafei
    Guo, Xiaopeng
    Cao, Dengfeng
    Gao, Xiaohuan
    DeLaney, Thomas F.
    Gong, Xinqi
    Chen, Rongrong
    Ni, Jianjiao
    Yao, Yong
    Wang, Renzhi
    Chen, Xi
    Tian, Pangzehuan
    Xing, Bing
    ONCOTARGET, 2016, 7 (28) : 43557 - 43569
  • [48] PROGNOSTIC IMPACT OF SOMATIC MUTATIONS ON TIME TO FIRST TREATMENT: RESULTS OF TARGETED NEXT-GENERATION SEQUENCING IN 211 PATIENTS WITH EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA
    Cristinelli, C.
    Varettoni, M.
    Orlandi, E.
    Zibellini, S.
    Rossi, M.
    Gentile, M.
    Flospergher, E.
    Ferretti, V. V.
    Rizzo, E.
    Della Porta, M. G.
    Rattotti, S.
    Cavalloni, C.
    Bergamini, F.
    Fabbri, N.
    Galli, A.
    Arcaini, L.
    HAEMATOLOGICA, 2021, 106 (10) : 40 - 41
  • [49] A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice
    Vasan, Neil
    Yelensky, Roman
    Wang, Kai
    Moulder, Stacy
    Dzimitrowicz, Hannah
    Avritscher, Rony
    Wang, Baliang
    Wu, Yun
    Cronin, Maureen T.
    Palmer, Gary
    Symmans, W. Fraser
    Miller, Vincent A.
    Stephens, Philip
    Pusztai, Lajos
    ONCOLOGIST, 2014, 19 (05): : 453 - 458
  • [50] Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia
    Varettoni, Marzia
    Orlandi, Ester
    Zibellini, Silvia
    Rossi, Marianna
    Gentile, Massimo
    Flospergher, Elena
    Ferretti, Virginia V.
    Rizzo, Ettore
    Della Porta, Matteo G.
    Rattotti, Sara
    Cavalloni, Chiara
    Bergamini, Fabio
    Cristinelli, Caterina
    Fabbri, Nicole
    Galli, Anna
    Arcaini, Luca
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (11) : E404 - E408
12345